CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 111 filers reported holding CLOVIS ONCOLOGY INC in Q4 2013. The put-call ratio across all filers is 0.91 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $7,323,000 | +4.6% | 79,635 | -0.1% | 0.20% | +17.0% |
| Q2 2015 | $7,003,000 | -66.4% | 79,685 | -71.6% | 0.17% | -68.3% |
| Q1 2015 | $20,847,000 | -9.8% | 280,846 | -32.0% | 0.54% | -9.1% |
| Q4 2014 | $23,120,000 | +30.3% | 412,857 | +5.6% | 0.59% | +22.0% |
| Q3 2014 | $17,742,000 | +4.9% | 391,146 | -4.3% | 0.49% | +0.8% |
| Q2 2014 | $16,917,000 | -9.5% | 408,529 | +51.4% | 0.48% | -20.4% |
| Q1 2014 | $18,689,000 | -0.3% | 269,798 | -13.3% | 0.61% | +4.1% |
| Q4 2013 | $18,752,000 | +25.8% | 311,132 | +26.9% | 0.58% | +19.0% |
| Q3 2013 | $14,901,000 | +101.3% | 245,086 | +121.8% | 0.49% | -75.4% |
| Q2 2013 | $7,401,000 | – | 110,490 | – | 1.99% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 814,833 | $60,485,054,000 | 53.20% |
| Palo Alto Investors LP | 2,121,857 | $157,505,000 | 7.79% |
| NEA Management Company, LLC | 2,279,781 | $169,228,000 | 7.65% |
| EcoR1 Capital, LLC | 243,048 | $18,041,000 | 6.01% |
| Redmile Group, LLC | 900,879 | $66,872,000 | 6.00% |
| Opaleye Management Inc. | 140,000 | $10,392,000 | 4.82% |
| PFM Health Sciences, LP | 2,266,756 | $168,261,000 | 4.64% |
| Partner Investment Management, L.P. | 40,798 | $3,028,000 | 4.56% |
| CLIFTON PARK CAPITAL MANAGEMENT, LLC | 826,919 | $61,383,000 | 3.74% |
| Opus Point Partners Management, LLC | 55,988 | $4,156,000 | 3.48% |